PTEN Alterations as a Potential Mechanism for Tumor Cell Escape from PD-1/PD-L1 Inhibition

The recent approval of immune checkpoint inhibitors drastically changed the standard treatments in many advanced cancer patients, but molecular changes within the tumor can prevent the activity of immunotherapy drugs. Thus, the introduction of the inhibitors of the immune checkpoint programmed death...

Descripción completa

Detalles Bibliográficos
Autores principales: Cretella, Daniele, Digiacomo, Graziana, Giovannetti, Elisa, Cavazzoni, Andrea
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6770107/
https://www.ncbi.nlm.nih.gov/pubmed/31500143
http://dx.doi.org/10.3390/cancers11091318

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6770107/
https://www.ncbi.nlm.nih.gov/pubmed/31500143
http://dx.doi.org/10.3390/cancers11091318

Ejemplares similares